DNLI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction SII Q1 2026 Earnings EPS Surprises Upward Despite Broader Market Headwinds ACHC Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution OFIX Q1 2026 Earnings Loss Narrower Than Expected Stock Declines Despite EPS Beat PRHI Q1 2024 Earnings Significant EPS Beat Fails to Impress Markets MSA Safety MSA Q1 2026 Earnings Solid EPS Beat Amid Steady Demand CAMT Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Beats Estimates as Pipeline Advances PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress HUBG Q3 2025 Earnings Modest EPS Miss Amid Positive Market Sentiment Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances